Diabetic Foot Protocol

An integrative, physician-designed approach for Indian adults living with diabetic foot ulcers, chronic non-healing wounds, or recurrent foot ulceration — anchored by ALIV’s PRP for Diabetic Foot specialty service, working alongside your diabetologist and vascular surgeon.

At a Glance

What it targets: The drivers of poor wound healing in diabetes — hyperglycemia, impaired angiogenesis, neuropathy, microvascular dysfunction, chronic inflammation, and nutritional deficits — combined with regenerative growth factor delivery directly to the wound bed.

Who it’s for: Adults with diabetes mellitus and an active diabetic foot ulcer, chronic non-healing wound, post-amputation residual ulceration, or history of recurrent foot ulceration, under diabetology and vascular care.

How it works: Physician-supervised, PRP-led approach — ALIV’s PRP for Diabetic Foot as the lead intervention, combined with glycemic and metabolic optimisation, micronutrient repletion, advanced wound care, and — in selected cases — autologous cell therapy.

What to expect: Wound healing rates and healing time improve meaningfully with PRP combined with structured care — multiple randomised controlled trials support this. Outcomes depend significantly on glycemic control, vascular status, infection burden, and adherence. ALIV does not guarantee wound closure, prevention of amputation, or any specific clinical outcome.

Who This Protocol Is For

Diabetic foot ulcer (DFU) is one of the most serious complications of diabetes and one of the most under-addressed in Indian medicine. A 2024 Indian SR/MA estimated the pooled DFU prevalence at 6.2% among people with diabetes, with substantially higher rates in men (14.5%) than women (7.7%). With India’s diabetes population now exceeding 100 million, the absolute number living with diabetic foot disease is enormous — and the consequences are severe: DFUs are a leading cause of hospitalisation, lower-limb amputation, and disability.

Standard care — glycemic control, wound debridement, dressings, infection management, offloading, vascular intervention where needed — is essential. But a significant proportion of ulcers remain non-healing despite optimal standard care, and recurrence rates are high. The regenerative layer can change outcomes here.

This protocol was built for you if:

• You have an active diabetic foot ulcer that is healing slowly or not at all despite standard wound care
• You have a chronic non-healing wound on the foot or lower limb related to diabetes
• You have a post-amputation site with residual ulceration or delayed healing
• You have a history of recurrent foot ulceration and want to break the cycle
• You have diabetic peripheral neuropathy with foot deformity or callus and want preventive care
• You’ve been told amputation may be required and want to explore regenerative options first

Important: This protocol is integrative supportive care, not replacement. Diabetic foot management is multidisciplinary — diabetology, vascular surgery, podiatry, and infectious disease all play essential roles. ALIV coordinates with your treating team. Active infection requires antibiotic management. Critical limb ischemia requires vascular evaluation.

How It Works — The ALIV Approach

Diabetic foot disease is fundamentally a multi-factor problem: hyperglycemia impairs every step of normal wound healing, microvascular disease reduces blood supply, neuropathy removes protective sensation, and chronic inflammation persists. The protocol addresses each, and adds regenerative growth factor delivery directly to the wound.

Layer 1 — Workup and Diagnostic Precision

Before any intervention, your ALIV physician runs: full ulcer characterisation (depth, size, infection status, Wagner or IDSA stage), vascular assessment (pulses, ankle-brachial index where indicated, referral to vascular surgery if concerns), neuropathy testing (monofilament, vibration), HbA1c, lipid panel, kidney function, micronutrient status (vitamin D, B12, zinc, iron, vitamin C, albumin), and infection screen.

Layer 2 — PRP for Diabetic Foot

ALIV’s PRP for Diabetic Foot is the lead intervention. Autologous platelet-rich plasma, prepared from your own blood, delivers a concentrated cargo of growth factors — PDGF, VEGF, TGF-β, EGF, FGF — directly to the wound bed, supporting angiogenesis, granulation tissue formation, epithelialisation, and the inflammatory phase essential for healing. The evidence is genuinely strong: multiple meta-analyses of randomised controlled trials show PRP significantly improves diabetic foot ulcer healing rate and shortens healing time compared to conventional care alone. Applied as injection around wound margins or topical/gel application, in repeat sessions across the healing period, coordinated with debridement and dressing schedule.

Layer 3 — Glycemic and Metabolic Foundation with Micronutrient Repletion

Wound healing in diabetes is fundamentally dependent on glycemic control — PRP and every other intervention work better with HbA1c in target range. The protocol coordinates with the Advanced Metabolic Reset Protocol where appropriate, including Tirzepatide where indicated, insulin sensitivity work, weight management, and lipid optimisation. Alongside this, targeted micronutrient repletion — vitamin D, zinc, vitamin C, B-complex, protein adequacy — directly supports wound repair.

Layer 4 — Wound Care and Infection Management

Standard wound care — regular debridement, advanced moisture-balanced dressings, and offloading (pressure on the wound prevents healing) — is coordinated with your treating team. Active infection requires antibiotic management by your physician. In clients with recurrent infections, immune dysregulation, or stubborn slow-healing wounds, Thymosin Alpha-1 can be added as an immune-balancing peptide to support host defence.

Layer 5 — Autologous Cell Therapy and Exosomes (If and When Indicated)

In advanced cases — large chronic wounds, failed conventional approaches, post-amputation residual ulceration — ALIV’s autologous cell therapy pathway and emerging exosome applications can be considered. Investigational; reserved for selected clients after PRP optimisation and specialist coordination. Outcomes not guaranteed.

What to Expect

The Lifestyle Layer — Daily Foot Care and Prevention

Daily foot inspection: most ulcers begin from minor unnoticed injury — cuts, blisters, pressure points, callus build-up. Daily visual check of soles, between toes, and pressure areas, ideally with a hand mirror or a family member’s help where vision or mobility is limited. Footwear: proper diabetic-friendly footwear with adequate depth, no internal seams, and supportive insoles is one of the highest-leverage preventive tools. Custom orthotics where deformity exists. Skin care: daily moisturising of dry skin (but not between toes); careful nail care — podiatry referral for any callus or ingrown nail. Smoking cessation: smoking dramatically worsens microvascular function and ulcer outcomes — cessation is non-negotiable. Glycemic discipline: medication adherence, diet quality, regular monitoring. Activity adaptation: offloading the wound during active healing is essential — partial weight-bearing or non-weight-bearing strategies as advised.

Frequently Asked Questions

How is this different from what my diabetologist or surgeon is already doing?

It complements, not replaces. Your diabetologist manages glycemic control and overall diabetes. Your surgeon manages wound debridement and surgical decisions. ALIV adds the regenerative layer — PRP for Diabetic Foot — plus integrated metabolic and lifestyle support. Best results come from all three working together.

How strong is the evidence for PRP in diabetic foot ulcers?

Strong, especially compared to many regenerative therapies. Multiple meta-analyses of randomised controlled trials — the highest tier of clinical evidence — demonstrate that PRP significantly improves healing rate and shortens healing time in diabetic foot ulcers compared to conventional care alone. PRP for Diabetic Foot is one of the better-evidenced regenerative therapies in chronic wound care.

Can PRP help me avoid amputation?

Honest answer: it can improve healing outcomes and may help avoid amputation in some cases, but it cannot guarantee that. The decision around amputation depends on infection control, vascular status, and tissue viability — issues your surgical team manages. PRP is most effective when introduced before tissue loss has progressed too far, which is why early engagement matters.

Is there a wait period after PRP before I can walk on my foot?

Offloading during the active healing period is critical regardless of PRP, and the offloading strategy is coordinated with your treating physician.

What about my blood thinners?

Many diabetic patients are on antiplatelet or anticoagulant medication. PRP can usually still be performed but requires careful timing and physician coordination. Your ALIV physician reviews your medication regimen as part of the workup.

Who should NOT do this protocol?

Active uncontrolled infection requiring inpatient management; critical limb ischemia requiring urgent vascular intervention as primary care; severe uncontrolled hyperglycemia requiring stabilisation first; clients seeking to bypass appropriate diabetology or surgical care.

Take the Next Step

A diabetic foot ulcer is a serious wound — but with the right combination of glycemic control, wound care, and regenerative support, healing outcomes can be substantially better than standard care alone. ALIV’s PRP for Diabetic Foot, integrated with your treating physicians, offers a meaningful addition.

To find out if the Diabetic Foot Protocol is right for you, speak with our medical team:

• Pune (Bund Garden): +91 77199 88811
• Mumbai (Khar West): +91 98220 93069

Or book a consultation through alivtherapy.in.

Research References

1. Singh KA, Beg MA, Nasrullah F, Singh G, Pinto AS, et al. Prevalence and risk factors associated with diabetic foot ulcer in India: a systematic review and meta-analysis. Int J Diabetes Dev Ctries. 2024. DOI: 10.1007/s13410-024-01400-x

2. Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;49(2):106-116. PMID: 27585407

3. Hu Z, Wang Y, Hua D, Wei L, Wang H. Efficacy of Platelet-Rich Plasma in the Treatment of Diabetic Foot Ulcers: A Systematic Review and Meta-Analysis. Ann Vasc Surg. 2023;98:A14-A25. PMID: 37355015

4. Liao X, Liang JX, Li SH, Huang S, Yan JX, Xiao LL, et al. Efficacy and safety of autologous platelet-rich plasma for diabetic foot ulcer healing: a systematic review and meta-analysis of randomized controlled trials. J Orthop Surg Res. 2023;18(1):370. PMID: 37202812

5. Driver VR, Hanft J, Fylling CP, Beriou JM, Autologel Diabetic Foot Ulcer Study Group. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage. 2006;52(6):68-87. PMID: 16799184

Disclaimer

The information on this page is for educational purposes only and is not intended as medical advice. ALIV therapies are not intended to diagnose, treat, cure, or prevent any disease, including diabetes mellitus, diabetic foot ulcer, diabetic peripheral neuropathy, peripheral arterial disease, or chronic non-healing wounds. This protocol is integrative supportive care provided alongside — not as a replacement for — specialist diabetology, vascular surgery, podiatry, and infectious disease management. Outcomes vary substantially; ALIV does not guarantee wound closure, prevention of amputation, or any specific clinical outcome. PRP for Diabetic Foot is supported by randomised controlled trial evidence for improved healing rate and time in diabetic foot ulcers, but individual response varies. Autologous cell therapy and exosome applications are investigational regenerative options; evidence is early-to-preliminary and they are not FDA-approved. Diabetes medications, antiplatelet/anticoagulant therapy, antibiotics, and other treatments prescribed by your treating team must be continued as directed. Active infection, critical limb ischemia, and severe uncontrolled hyperglycemia require primary medical management before regenerative layers. Please consult a qualified healthcare professional before starting any therapy programme.